Turning Science into Hope
A CRO built to move faster. Our wide global coverage and integrated therapeutic platforms deliver broader patient access, strategic regulatory advantage, and the ability to move science into hope for patients through scientific integrity, prioritisation and operational excellence.
2x more reach across North America and Europe than the average mid-sized CRO
Partnered On
Approved Therapeutics
Therapeutic Expertise
I would like to thank you all for the tremendous work done to reach this important milestone for the study in a very challenging and complex global environment. It is the first of many others that we will have to achieve together. Let's keep it up!
Clinical Project Leader, Big Pharma Company
We are very grateful for your hard work and dedication over the past few years. We are delighted to be part of this partnership and look forward to start treating patients in this new therapeutic area soon. We could not have done this without your contribution. We are very excited about the path ahead and can hardly wait to start this study.
Chief Executive Officer, Biotech Company
Very pleased. Looking forward to getting the country up and running soon.
VP Global Clinical Operations, Medical Device Company
On behalf of the entire team, I would like to extend our deepest appreciation and heartfelt thanks for your unwavering support and dedication throughout this phase II clinical study. Your role was critical to this success, and it has been a privilege to work alongside you.
Head of Clinical Operations, Bio-pharma Company
We’re proud to announce the first patient has been enrolled in our Phase 1b/2 trial of a novel, in-house developed drug for colorectal cancer. This marks a key milestone in its clinical development. We thank our dedicated team and our trusted CRO partner, Optimapharm, for their expertise and support.
Chief Medical Officer, Biotech Company